"Maryland Father" Or MS-13 Migrant Gangster. Which Is It, MSM?

 Left-leaning corporate media unleashed another info war against the Trump administration after The Atlantic published an overnight story titled "An 'Administrative Error' Sends a Maryland Father to a Salvadoran Prison." However, the struggling outlet behind "SignalGate" conveniently omitted a key detail in the headline: the deported migrant held a "prominent role in MS-13," according to court filings. Notably, this Mexican drug cartel has been officially designated as a Foreign Terrorist Organization by the Trump administration.

The omission in the title was no accident. Details matter, and this appears to be a concerted effort by the left to sway public opinion as the Democratic Party implodes in polling data over its disastrous Tesla Takedown color revolution operation that, in some instances, has resulted in domestic terrorism attacks against Tesla showrooms, service centers, and vehicles nationwide.

MSM conveniently labeled the migrant MS-13 gangster as "Maryland Father" in the headlines ... and that's all you need to know about their slant (migrant gangsters > national security of citizens). 

Many X users fact-checked MSM's reporting, including Will Chamberlain, Senior Counsel at the Internet Accountability Project and the Article III Project, who said, "In an article this evening, The Atlantic pretended that a deported MS-13 gang member was merely a "Maryland father."" 

Before MS13 migrant gangster Kilmar Armando Abrego Garcia was removed from the US, he had been arrested by Immigration and Customs Enforcement in mid-March "due to his prominent role in MS-13," according to a court declaration from ICE. 

MSM and Dems only fixated on this from the filing: "On March 15, although ICE was aware of his protection from removal to El Salvador, Abrego Garcia was removed to El Salvador because of an administrative error." However, even as the filing admits the error, it continued: "final order of removal and Abrego-Garcia's purported membership in MS-13."

Democrats attempted a 'gotcha moment' with Vice President J.D. Vance...

The VP responded:

My comment is that according to the court document you apparently didn't read he was a convicted MS-13 gang member with no legal right to be here. My further comment is that it's gross to get fired up about gang members getting deported while ignoring citizens they victimize.

VP Vance added in a separate X post:

"It is telling that the entire American media is going to run a propaganda operation today making you think an innocent "father of 3" was apprehended by a gulag." 

Trump has made it very clear through executive orders that migrant gangsters—especially those affiliated with FTOs such as Tren de Aragua and MS-13—will be deported. The mainstream media and the Democratic Party are furious because their future criminal migrant voters are being deported, and their end goal of a one-party state - like California - is being derailed. 

Democrats have chosen migrant gangsters over national security and the safety of law-abiding citizens. This is alarming. 

https://www.zerohedge.com/political/maryland-father-or-ms-13-migrant-gangster-which-it-msm

Merck’s Winrevair Cuts Morbidity, Mortality Risk by Over 75% in Phase III PAH Study

 

Merck continues to build the case for the pulmonary arterial hypertension drug that won FDA approval in 2024.

In high-risk patients with pulmonary arterial hypertension, Merck’s fusion protein therapeutic Winrevair reduced the likelihood of major morbidity and mortality by 76% in the Phase III ZENITH trial.

Analysts at Guggenheim Partners called this outcome “striking” and “very impressive” in a note to investors Monday, pointing to improvements in key secondary outcomes in overall survival and transplant-free survival.

The Guggenheim analysts also pointed out that Winrevair had “relatively consistent improvements” in mortality and morbidity across patient subgroups, including age, sex and disease subtype and severity.

In November 2024, Merck announced that, following the recommendations of an independent data monitoring board, it was stopping ZENITH ahead of schedule due to “overwhelming efficacy.” On Monday, the pharma revealed that in the Winrevair arm, 17.4% of patients experienced at least one major morbidity or mortality event, as opposed to 34.7% of placebo comparators.

The data were presented at the 2025 American College of Cardiology’s Annual Scientific Session and Expo and simultaneously published in The New England Journal of Medicine.

Winrevair is a recombinant activin receptor type IIA-Fc fusion protein that targets and binds to activin A and other ligands that belong to the TGF-β superfamily. This mechanism of action allows Winrevair to restore balanceto vascular proliferation, a key pathway that is altered in pulmonary arterial hypertension (PAH). In particular, PAH patients see high excessive cell proliferation in key arteries, leading to thickened blood vessel walls and, in turn, impaired blood flow.

Winrevair was approved by the FDA to treat PAH in March 2024, making it the first-ever drug for the disease that targets activin signaling.

Merck continues to build its evidence base for Winrevair. In March 2023, the pharma unveiled full data from the Phase III STELLAR trial, touting a 40.8-meter improvement in 6-minute walk distance in patients with PAH following treatment with the drug. Winrevair also cut the risk of death or clinical worsening by 84% versus placebo.

Merck is also running the Phase III HYPERION study to assess the benefit of Winrevair when used with background therapy. In January 2025, the company ended the trial ahead of schedule, in line with the recommendations of an external committee, because of strong efficacy findings in an interim analysis. Results from HYPERION will be presented later this year, according to Merck’s Monday announcement.

https://www.biospace.com/drug-development/mercks-winrevair-cuts-morbidity-mortality-risk-by-over-75-in-phase-iii-pah-study

Altria Stops Selling NJOY Ace E-Cigarettes in Patent Dispute With Juul

Tobacco giant Altria Group has stopped selling its NJOY Ace e-cigarettes, after the U.S. International Trade Commission sided with rival Juul Labs in a patent dispute. Consumers can still buy them in stores until retailers' existing inventory runs out.

The ruling was a setback for Altria, which in 2023 divested its investment in Juul and agreed to buy NJOY for at least $2.75 billion. Juul then filed a complaint with the ITC, alleging that the NJOY Ace infringed on its patents. The ITC in January ordered Altria to stop importing, distributing and marketing the devices by March 31. Shares of Altria were down about 2% in midday trading Tuesday.

Among the NJOY products removed from the market is the only menthol vaping product authorized for sale in the U.S. by the Food and Drug Administration. Altria Chief Executive Billy Gifford, on a January conference call with analysts, said the ITC's decision limits consumers' choices and "undermines public health, especially in context of a market that is overrun by illicit products."

https://www.marketscreener.com/quote/stock/ALTRIA-GROUP-INC-4837/news/Altria-Stops-Selling-NJOY-Ace-E-Cigarettes-in-Patent-Dispute-With-Juul-49501458/

Visa Offers Apple Roughly $100 Million To Take Over Credit Card From Mastercard- WSJ

 On Tuesday, Visa (NYSE:V) made a significant move to secure its position in the competitive payment network industry by offering Apple (NASDAQ:AAPL) approximately $100 million. The bid is an attempt to replace Mastercard (NYSE:MA) as the network for the Apple credit card, according to The Wall Street Journal, citing people familiar with the matter.

This effort comes as Goldman Sachs (NYSE:GS), the current bank supporting the Apple card, plans to exit the consumer lending sector. Visa’s proposition is part of a larger contest among leading payment networks, which also includes American Express (NYSE:AXP), to win over the lucrative partnership with Apple.

The Apple card has become a coveted asset, with major banks such as JPMorgan Chase (NYSE:JPM) and Synchrony Financial (NYSE:SYF) already in the race to become the new issuer. However, the battle for the network side of the operation has been just as intense. Visa, being the largest network, has made an aggressive offer that includes the type of upfront payment typically reserved for top-tier card programs.

American Express is also pursuing a dual role in this deal, aiming to be both the issuer and network for the Apple card. In 2023, Goldman Sachs reached out to American Express to explore their interest in taking over the card, signaling the potential for significant changes in the card’s operation.

Meanwhile, Mastercard is not stepping down without a fight, as it actively seeks to retain its position as the network for the Apple card, according to the unnamed sources.

The networks are essential components of the payment process, facilitating the transmission of information between the banks that issue consumer cards and the banks of merchants. The selection of a network by Apple is anticipated to precede the choice of a bank to replace Goldman Sachs, highlighting the importance of this decision in the financial industry.

https://uk.investing.com/news/stock-market-news/visa-bids-100-million-to-snag-apple-card-from-mastercard--wsj-93CH-4009130

Ukraine to hold 'in-depth' talks on foreign troop contingent Friday, Zelenskiy says

 Ukraine will hold in-depth talks on Friday with a small group of foreign countries about contributing forces to a contingent that would act as a security guarantee for Ukraine, President Volodymyr Zelenskiy said on Tuesday.

The Ukrainian leader told a news conference with Germany's foreign minister that he was awaiting "more concrete" answers from Kyiv's allies on their readiness to participate in such a force, an initiative Russia strongly opposes.

"As far as the matter of a contingent goes, we will have a meeting on Friday. It will be a meeting of our military teams, several countries, a narrow circle of countries that will be ready to deploy a contingent in one form or another," he said.

Zelenskiy said that the contingent would include a land component, an air component and a presence at sea.

U.S. President Donald Trump has said he wants to end the three-year-old conflict in Ukraine that began with Russia's full-scale invasion in 2022.

Washington last week brokered a halt between the two countries on strikes against each other's energy infrastructure.

The U.S. has hoped to reach a full ceasefire followed by a lasting peace settlement. But an agreement appears distant despite Trump's promises to bring the conflict to a quick end.

Kyiv's European allies have expressed willingness to contribute troops to a force that would provide security guarantees to Ukraine under a ceasefire and to strengthen Ukraine's military long term.

"This will be the first in-depth meeting, (before that) there were consultations. I think we will see some clarifications and some details," Zelenskiy said of Friday's meeting.

He added that it was not only the contingent under discussion. "It is very important how the future of the Ukrainian army will look like," he said.

A spokesperson for British Prime Minister Keir Starmer said on Monday that British, French and Ukrainian military leaders would meet in the coming days to build on "real momentum" in efforts to boost Ukraine's security.

The Ukrainian leader also used the news conference to urge the United States to ramp up sanctions on Russia for what he said were violations of the ceasefire on energy infrastructure.

He said that the United States had told the Ukrainians privately that it had seen Russian violations of the agreement, which emerged from talks held in Saudi Arabia last week.

Russia has itself accused the Ukrainians of continuing to strike energy infrastructure, something Kyiv denies.

Trump rapidly reoriented American policy on the war since taking office in January, resuming direct dialogue with Russia, while at times piling pressure on Ukraine, for instance by temporarily cutting arms supplies and intelligence sharing.

This week, the United States proposed a dramatically expanded minerals deal with Ukraine, a summary of which seen by Reuters suggested that Washington was demanding all Ukraine's natural resources income for years.

Zelenskiy, who wants the White House as a close partner and has been cautious in his public pronouncements on the deal, told reporters on Tuesday that Ukrainian and American teams were working on a draft.

But Ukraine, he said, would have to nominate a legal company to work on the draft, a decision that would be made in the coming days.

https://www.aol.com/ukraine-hold-depth-talks-foreign-174403306.html

Hims & Hers to sell Lilly's Zepbound on its telehealth platform

 Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's diabetes and weight-loss drugs on its platform.

Shares of the company were up 8.5% in afternoon trading.

The telehealth firm is following its peers Teladoc and LifeMD in offering Lilly's Zepbound ahead of restrictions on selling copies known as compounded drugs.

The company said it will offer both branded versions of Lilly's tirzepatide — the active ingredient in weight-loss drug Zepbound and diabetes medicine Mounjaro — as well as generics of Novo Nordisk's diabetes drug, liraglutide.

Hims & Hers previously only offered cheaper versions of Novo's weight-loss drug Wegovy.

Shares of the company have fallen 40% since the U.S. FDA removed Novo's top-selling Wegovy and diabetes drug Ozempic from its shortage list on February 21.

Without a shortage, compounders may not produce copies of the branded drugs regularly or in large amounts, according to FDA guidance.

The FDA said in March it will not take action against compounding pharmacies making copies of Wegovy until a federal court delivers its ruling in a lawsuit against the agency.

The FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make compounded drugs in bulk — have until April 22 and May 22 respectively, or until the court decides on the injunction, to stop making Wegovy copies, whichever comes later.

https://finance.yahoo.com/news/hims-hers-sell-lillys-zepbound-173933245.html

Organized 'Bankrupt Tesla' Group Tied To Formerly USAID-Funded Disinfo Queen

 On Tuesday morning, former Biden administration "disinformation czar" Nina Jankowicz repeatedly refused to disclose who's funding her new gig - the 'American Sunlight Project' - which cropped up after a stint at the USAID-funded UK-based Centre for Information Resilience (CIR) - for which she registered as a foreign agent while serving as their Vice President.

To review - Jankowicz, who previously served as a disinformation fellow at the Wilson Center, advised the Ukrainian Foreign Ministry as part of the Fulbright-Clinton Public Policy Fellowship, and was then selected to head the Biden DHS's newly formed Disinformation Governance Board - which was quickly dismantled amid criticism over censorship under the guise of fighting disinformation. 

Four months later, she launched "The Hypatia Project" for CIR - where she was the Vice President until April 2024, at which point she co-founded the American Sunlight Project.

Fast forward to this morning, Jankowicz was evasive when asked by Republicans during a congressional hearing on disinformation about her funding...

Nina Jankowicz, the short-lived head of Biden’s Disinformation Governance Board aka Disinformation Czar refuses to say if her new org, The American Sunlight Projegt, is funded by George Soros.

“So sunlight for other people but not for your donors” @RepBaumgartner quips… pic.twitter.com/2RIiI1VU16

— Rob (@RobMcGravytrain) April 1, 2025

Well, Well, Well

As it turns out, Jankowicz's co-founder at the American Sunlight Project is Carlos Alvarez-Aranyos, a "communications professional" who worked for the Biden DoD, and is "one of the people who launched the call for a boycott of Tesla."

Alvarez-Aranyos comes from a wealthy and prominent family in the Dominican Republic. His father, Luis Álvarez Renta, is a well-known Dominican financier. Carlos is a nephew of the renowned fashion designer Oscar de la Renta.

Biden's censorship queen Nina Jankowicz currently works at the American Sunlight Project (ASP), and previously worked at USAID-funded Center for Information Resilience.

The ASP was co-founded by Carlos Alvarez-Aranyos is a "communications professional" who worked for Biden's… https://t.co/uIgDszSDKL pic.twitter.com/x60Ju2wzYh

— zerohedge (@zerohedge) April 1, 2025

“I need to have on my resume, so I can get a job when this thing is over, that I bankrupted Tesla.”

This is an outright admission the top Tesla boycott organizers’ personal financial prospects depend on taking down Tesla, and they must succeed in order to get paid. https://t.co/CJnQDX38rC pic.twitter.com/Ti775yTplt

— Mike Benz (@MikeBenzCyber) March 30, 2025

Alvarez-Aranyos has been scrubbed from the American Sunlight Project's website, which is why the internet archive exists.

Early organizers of the "Tesla Takedown" protests said last month that the organization's goal is to drive down the price of Tesla stock.

Another "Tesla Takedown" organizer, Edward Niedermeyer, told Fortune Magazine that dropping Musk's wealth is exactly their aim.

"The goal, I would say, is to bankrupt Elon Musk—bring down his empire," he said.

Read more on the Tesla Takedown organizers here...

Musk chimed in, calling the organizers "Evil people..."

Evil people https://t.co/6NCHAzZC9B

— Elon Musk (@elonmusk) April 1, 2025

https://www.zerohedge.com/political/evil-people-organized-bankrupt-tesla-group-tied-formerly-usaid-funded-disinfo-queen